Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis

Journal of Nutrition

Volumn 140, Issue 11, 2010, Pages 2014-2019

  López Posadas, Rocío ^a   Requena, Pilar ^a   González, Raquel ^a   Suárez, María Dolores ^a   Zarzuelo, Antonio ^a   Sánchez De Medina, Fermín ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DRINKING WATER; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MYELOPEROXIDASE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; CASEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; GLYCOPEPTIDE; KAPPA CASEIN GLYCOMACROPEPTIDE; KAPPA-CASEIN GLYCOMACROPEPTIDE; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PTGS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; DISEASE ACTIVITY; EX VIVO STUDY; FEMALE; INFLAMMATORY INFILTRATE; INTESTINE EPITHELIUM; LYMPH NODE CELL; MESENTERY LYMPH NODE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBMUCOSA; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COLON; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENTERITIS; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; LYMPH NODE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; SECRETION; WISTAR RAT;

BACTERIA (MICROORGANISMS); BOVINAE; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASEINS; CELLS, CULTURED; COLITIS; COLON; CYCLOOXYGENASE 2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLYCOPEPTIDES; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; LYMPH NODES; NEUTROPHIL INFILTRATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 78149277478     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.118448     Document Type: Article

References (36)

1. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis. 2004;10 Suppl 1:S32-4.
2. Sands BE. Therapy of inflammatory bowel disease. Gastroenterology. 2000;118:S68-82.
3. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446: 557-61.
4. Sainathan SK, Hanna EM, Gong Q, Bishnupuri KS, Luo Q, Colonna M, White FV, Croze E, Houchen C, et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis. 2008;14:88-99.
5. Qualls JE, Tuna H, Kaplan AM, Cohen DA. Suppression of experimental colitis in mice by CD11c+ dendritic cells. Inflamm Bowel Dis. 2009;15:236-47.
6. Qualls JE, Kaplan AM, van Rooijen N, Cohen DA. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol. 2006;80:802-15.
7. Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42:16-25.
8. Brody EP. Biological activities of bovine glycomacropeptide. Br J Nutr. 2000;84:S39-46.
9. Nakano T, Silva-Hernandez ER, Ikawa N, Ozimek L. Purification of kappa-casein glycomacropeptide from sweet whey with undetectable level of phenylalanine. Biotechnol Prog. 2002;18:409-12.
10. Nakay S, Modler HW. Food proteins. Processing applications. New York: Wiley-VCH; 1999.
11. Bruck WM, Kelleher SL, Gibson GR, Nielsen KE, Chatterton DEW, Lonnerdal B. rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant Rhesus monkeys challenged with enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr. 2003; 37:273-80.
12. Bruck WM, Graverholt G, Gibson GR. A two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype typhimurium. J Appl Microbiol. 2003;95:44-53.
13. Requena P, Daddaoua A, Guadix E, Zarzuelo A, Suarez MD, Sanchez de Medina F, Martinez-Augustin O. Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. Br J Pharmacol. 2009;157:1232-40.
14. Fomon SJ. (1993) Nutrition of normal infants. St. Louis: Mosby Yearbook Inc; 1993.
15. Monnai M, Otani H. Effect of bovine k-caseinoglycopeptide on secretion of interleukin-1 family cytokines by P388D1 cells, a line derived from mouse monocyte/macrophage. Milchwissenschaft. 1997;52:192-6.
16. Otani H, Monnai M, Kawasaki Y, Kawakami H, Tanimoto M. Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine kappa-caseinoglycopeptides having different carbohydrate chains. J Dairy Res. 1995;62:349-57.
17. Monnai M, Horimoto Y, Otani H. Immunomodificatory effect of dietary bovine kappa-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice. Milchwissenschaft. 1998;53:129-32.
18. Requena P, Daddaoua A, Martínez-Plata E, González M, Zarzuelo A, Suárez MD, Sánchez de Medina F, Mart́nez- Augustin O. Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. Br J Pharmacol. 2008; 154:825-32.
19. Daddaoua A, Puerta V, Zarzuelo A, Suarez MD, Sanchez de Medina F, Martinez-Augustin O. Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr. 2005;135:1164-70.
20. Daddaoua A, Puerta V, Requena P, Martinez-Ferez A, Guadix E, de Medina FS, Zarzuelo A, Suarez MD, Boza JJ, et al. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J Nutr. 2006;136:672-6.
21. Pérez-Navarro R, Ballester I, Zarzuelo A, Sánchez de Medina F. Disturbances in epithelial ionic secretion in different experimental models of colitis. Life Sci. 2005;76:1489-501.
22. Sanchez de Medina F, Martinez-Augustin O, Gonzalez R, Ballester I, Nieto A, Galvez J, Zarzuelo A. Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem Pharmacol. 2004;68:2317-26.
23. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Iwakura Y, et al. Involvement of IL17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun. 2008;377:12-6.
24. Ballester I, Daddaoua A, Lopez-Posadas R, Nieto A, Suarez MD, Zarzuelo A, Martinez-Augustin O, Sanchez de Medina F. The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats. Br J Pharmacol. 2007;151: 206-15.
25. Martinez-Augustin O, Merlos M, Zarzuelo A, Suarez MD, Sanchez de Medina F. Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics. 2008;9:490.
26. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81-92.
27. Karrasch T, Kim JS, Jang BI, Jobin C. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB (EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS ONE. 2007;2:e596.
28. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-49.
29. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795-803.
30. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101:540-7.
31. Longo WE, Panesar N, Mazuski J, Kaminski DL. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. Prostaglandins Other Lipid Mediat. 1998;56:325-39.
32. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology. 1998;115:297-306.
33. Obermeier F, Dunger N, Deml L, Herfarth H, Scholmerich J, Falk W. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol. 2002;32:2084-92.
34. Carrier JC, Aghdassi E, Jeejeebhoy K, Allard JP. Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB. Int J Colorectal Dis. 2006;21:381-7.
35. Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, et al. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol. 2003;18:560-9.
36. Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med. 2004;14:191-6.